| MR-guidance in clinical reality: current treatment challenges and future perspectives S Corradini, F Alongi, N Andratschke, C Belka, L Boldrini, F Cellini, ... Radiation Oncology 14, 1-12, 2019 | 321 | 2019 |
| Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases—a pooled analysis of the German working group “stereotactic radiotherapy” J Rieber, J Streblow, L Uhlmann, M Flentje, M Duma, I Ernst, O Blanck, ... Lung Cancer 97, 51-58, 2016 | 163 | 2016 |
| The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients … RJ Klement, N Abbasi-Senger, S Adebahr, H Alheid, M Allgaeuer, ... Bmc Cancer 19, 1-12, 2019 | 85 | 2019 |
| Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease S Tanadini-Lang, J Rieber, AR Filippi, MM Fode, J Streblow, S Adebahr, ... Radiotherapy and Oncology 123 (2), 182-188, 2017 | 64 | 2017 |
| Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma S Adeberg, SB Harrabi, N Bougatf, D Bernhardt, J Rieber, SA Koerber, ... Strahlentherapie und Onkologie 192 (11), 770, 2016 | 63 | 2016 |
| Influence of institutional experience and technological advances on outcome of stereotactic body radiation therapy for oligometastatic lung disease J Rieber, N Abbassi-Senger, S Adebahr, N Andratschke, O Blanck, ... International Journal of Radiation Oncology* Biology* Physics 98 (3), 511-520, 2017 | 55 | 2017 |
| First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany S Klüter, S Katayama, CK Spindeldreier, SA Koerber, G Major, M Alber, ... Strahlentherapie und Onkologie 196, 691-698, 2020 | 53 | 2020 |
| Intensity modulated radiation therapy (IMRT) with simultaneously integrated boost shortens treatment time and is noninferior to conventional radiation therapy followed by … J Hörner-Rieber, T Forster, A Hommertgen, MF Haefner, N Arians, ... International Journal of Radiation Oncology* Biology* Physics 109 (5), 1311-1324, 2021 | 52 | 2021 |
| Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma—a multicenter analysis of the German working group “Stereotactic Radiotherapy” J Hoerner-Rieber, M Duma, O Blanck, G Hildebrandt, A Wittig, F Lohaus, ... Journal of thoracic disease 9 (11), 4512, 2017 | 52 | 2017 |
| Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients L König, MF Häfner, S Katayama, SA Koerber, E Tonndorf-Martini, ... Radiation Oncology 15, 1-9, 2020 | 50 | 2020 |
| Correlating dose variables with local tumor control in stereotactic body radiation therapy for early-stage non-small cell lung cancer: a modeling study on 1500 individual … RJ Klement, JJ Sonke, M Allgäuer, N Andratschke, S Appold, J Belderbos, ... International Journal of Radiation Oncology* Biology* Physics 107 (3), 579-586, 2020 | 48 | 2020 |
| Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas J Rieber, J Schmitt, A Warth, T Muley, J Kappes, F Eichhorn, H Hoffmann, ... European journal of medical research 20, 1-8, 2015 | 48 | 2015 |
| Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis RA El Shafie, K Böhm, D Weber, K Lang, F Schlaich, S Adeberg, A Paul, ... Cancer management and research, 789-801, 2019 | 47 | 2019 |
| Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy RJ Klement, J Hoerner-Rieber, S Adebahr, N Andratschke, O Blanck, ... Radiotherapy and oncology 127 (2), 246-252, 2018 | 47 | 2018 |
| Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapy J Hörner-Rieber, D Bernhardt, J Dern, L König, S Adeberg, A Paul, ... Radiotherapy and Oncology 125 (2), 317-324, 2017 | 47 | 2017 |
| Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy D Bernhardt, S Adeberg, F Bozorgmehr, N Opfermann, J Hoerner-Rieber, ... Journal of neuro-oncology 134, 205-212, 2017 | 46 | 2017 |
| ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology S Corradini, F Alongi, N Andratschke, D Azria, O Bohoudi, L Boldrini, ... Radiotherapy and Oncology 159, 146-154, 2021 | 43 | 2021 |
| Long-term follow-up and patterns of recurrence of patients with oligometastatic NSCLC treated with pulmonary SBRT J Hörner-Rieber, D Bernhardt, O Blanck, M Duma, HT Eich, S Gerum, ... Clinical lung cancer 20 (6), e667-e677, 2019 | 43 | 2019 |
| Palliative radiotherapy for leptomeningeal carcinomatosis–analysis of outcome, prognostic factors, and symptom response RA El Shafie, K Böhm, D Weber, K Lang, F Schlaich, S Adeberg, A Paul, ... Frontiers in oncology 8, 641, 2019 | 40 | 2019 |
| Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy D Bernhardt, S Aufderstrasse, L König, S Adeberg, F Bozorgmehr, ... Cancer management and research, 6563-6569, 2018 | 40 | 2018 |
